Clinical Trial

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

Name: 68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors — clinical trial record (NCT05673031)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To determine if 68Ga-HA-DOTATATE PET/CT imaging is effective at diagnosing somatostatin positive tumors compared to conventional imaging \[including CT, MRI, 111 In-pentetreotide Scans, 18F-FDG PET/CT, as available\]

Trial Details

NCT Number	NCT05673031
Lead Sponsor	Alberta Health services
Conditions	Neuroendocrine Tumors (NET)
Enrollment	500 participants
Start Date	2023-02-01
Primary Completion	2027-01-01 (estimated)
Study Completion	2027-01-01 (estimated)
Updated on ClinicalTrials.gov	2023-01-05